To identify the novel inhibitors of endoplasmic reticulum stress-induced cell death, we performed a high throughput assay with a chemical library containing a total of 3,280 bioactive small molecules. Cyclosporine A and bromocriptine were identified as potent inhibitors of thapsigargiin-induced cell death (cut-off at 4σ standard score). However, U74389G, the potent inhibitor of lipid peroxidation had lower activity in inhibiting cell death. The inhibition effect of cyclosporine A and bromocriptine was specific for only thapsigargin-induced cell death. The mechanism of inhibition by these compounds was identified as modification of the expression of glucose regulated protein-78 (GRP-78/Bip) and inhibition of phosphorylation of p38 mitogen activated protein kinase (MAPK). However, these compounds did not inhibit the same events triggered by tunicamycin, which was in agreement with the cell survival data. We suggest that the induction of protective unfolded protein response by these compounds confers resistance to cell death. In summary, we identified compounds that may provide insights on cell death mechanisms stimulated by ER stress. [BMB Reports 2012; 45(8): 482-487]
INTRODUCTION
The endoplasmic reticulum (ER) is a key intracellular organelle, where protein quality control systems regulate folding and post-translational modifications of proteins, as well as selection of protein transport to intracellular compartments or secretion (1) (2) (3) . A wide range of disturbances leads to accumulation of unfolded proteins in the ER (2, 4, 5) , including (a) impaired redox control (6) , (b) impaired cellular Ca 2+ regulation (7), (c) high fat diet; (d) hyperglycemia (8) , (e) virus infection, and (f) glucose deprivation. Three ER transmembrane proteins have been identified as the proximal sensors of an unfolded protein response (UPR): endoribonuclease (IRE-1), PKR-like ER kinase (PERK), and the leucine-zipper motif containing transcriptionfactor (ATF6) (4) . The primary aim of the UPR is to recover homeostasis and normal function of the ER by shutting down global protein translation, and by activating transcriptional pathways that induce expression of genes to help protein folding and degradation in the ER. If the UPR is unsuccessful in restoring normal cell status, the apoptotic machinery induces cell death. The ER stress plays an important role in a variety of diseases, including neurodegenerative disorders and metabolic diseases (9) . Therefore, the identification of inhibitors of ER stress-induced cell death may provide new insights into ER stress-related diseases. In the present study, we have utilized a high throughput screening method for the identification of inhibitors of cell death induced by ER stress. Specifically, we found that the immunosuppressant cyclosporine A, the dopamine receptor D2 agonist bromocriptine, and U74389G, the inhibitor of lipid peroxidation suppressed cell death resulting from incubation with thapsigargin, which is an irreversible inhibitor of the ER Ca 2+ ATPase.
RESULTS

High throughput screen for inhibitors of thapsigargin-induced cell death
To identify inhibitors of ER stress-induced cell death, we developed a high throughput screening (HTS) assay employing thapsigargin (an irreversible inhibitor of the ER Ca 2+ ATPase) and CSM 14.1 cells (a rat striatal neuronal progenitor cell line). Experiments were performed at permissive temperature (optimal at 32 o C) (10, 11) . As a positive control for each test plate, salubrinal, a known inhibitor of ER stress-induced cell death was employed (12) . The robustness of the assay was assessed by calculating the Z' factor of each test plate using a positive control (salubrinal in DMSO followed by thapsigargin), and negative control (DMSO followed by thapsigargin) (13, 14) . Two specific chemical libraries (LOPAC TM from Sigma, and Spectrum collection TM from Microsource Discovery) enriched with pharmacologically active small molecules (Fig. 1) , at concentrations of 10 μM, were screenedfor their ability to inhibit thapsigargin-induced cell death. The CSM 14.1 cells were pre-http://bmbreports.org BMB Reports incubated with each compound for 2 hours, and exposed to 15 μμM thapsigargin for another 20 hours (Fig. 1A) . Screening of 3280 bioactive chemical compounds yielded 5 primary hits (cut off ＞4σ by standard score). These compounds were re-tested, thus yielding 3 reproducible hits, resulting in a hit rate of 0.09% (Fig. 1E, F and Table 1 ). Cyclosporine A and U74389G were present in both the libraries, with bromocriptine mesylate present in the Spectrum collection (Table 1) .
Cytoprotective activity of compounds confirmed in additional cell lines
The ability of the identified compounds to inhibit thapsigargin-induced cell death in various cell lines, including the MDA-MB-231 (breast cancer), A549 (lung cancer), HCT-116 (colon cancer), SK-Mel and RPMI7951 (melanoma), and HeLa (cervical carcinoma) cell lines was tested. It was found that all the three compounds inhibited thapsigargin-induced cell death in all the tested cell lines (Fig. 2) , thus confirming their cytoprotective activity in cells from several organ sites. Although the tested compounds showed similar levels of inhibition in HCT116 cells, bromocriptine was found to be less potent than cyclosporine A in all other cell lines, whereas the activity of U74389G varied based on the cell type. The ability of cyclosporine A and bromocriptine to block thapsigargin-induced cell death was effective for at least 20 hours (data not shown).
The potency of these three compounds was determined by performing dose-response experiments using HeLa and MDA-MB-231 cells ( The next day, the cells were incubated with DMSO or hit compounds (20 μM) for 2 hours, followed by treatment with various cell death-inducing reagents, including 15 μM thapsigargin (TG) for 10 hours, 10 μg/ml tunicamycin (TUN) for 48 hours, 2.5 μM staurosporine (STS) for 24 hours, 10 μM brefeldin A (BFA) for 36 hours, 50 μM VP16 for 48 hours, or 30 ng/ml TNF-α (TNF). plus 10 μg/ml cycloheximide (CHX) for 24 hours. Cellular ATP content was measured in all the samples, with the data normalized relative to cells treated with DMSO alone, and presented as a percentage of control (mean ± SD, n = 3). μM hit compounds in DMSO for 2 hours, followed by treatment with 10 μM thapsigargin. Cell lysates were analyzed by SDS-PAGE/immunoblotting using the indicated antibodies. (B) Total RNAs were prepared from the cells in (A) and purified RNA was subjected to reverse transcription-polymerase chain reaction using the human XBP1 primers,: 5'-CAGAGTAGCAGCACAGACTGC-3' (forward) and 5'-TCCTTCTGGGTAGACCTCTGGGAG-3' (reverse) (C) HeLa cell extracts were prepared as in (A) but 10 μg/ml tunicamycin was used to induce ER stress with or without hit compounds (20 μM). Inactivation of eIF2-α by phosphorylation of serine 51 residue was visualized by immunoblotting using anti phosphor eIF2-α antibody.
gargin-induced cell death in a dose-dependent manner. The IC50 values for cyclosporine A were 4.6 μM in HeLa cells and 3.0 μM in MDA-MB-231 cells; whereas the IC50 values for bromocriptine were 5.4 μM in HeLa cellsand 2.7 μM in MDA-MB-231 cells (Table 2) .
To examine the specificity of cytoprotection, the activity of the compounds was explored using experimental conditions that stimulate non-ER stress cell death pathways and cell death stimulated by other inducers of ER stress. To this end, HeLa cells were challenged with a variety of cell death signal-inducing stimuli, including tunicamycin (an N-linked glycosylation inhibitor and ER stress inducer), brefeldin A (ER transport inhibitor and ER stress inducer), VP16 (a DNA-damaging agent), staurosporine (STS) (a pan-kinase inhibitor, and Tumor Necrosis Factor-α (TNF-α) (an activator of death receptor-mediated apoptosis). It was observed that none of the three compounds inhibited cell death initiated by other reagents, thus exhibiting protection specifically for thapsigargin-induced cell death. These findings therefore suggest that the three compounds identified by our HTS inhibits Ca
2+
-dependent cell death mechanisms that occur when Ca 2+ is released from the ER, and indicates that they are not broad-spectrum inhibitors of ER stress (Fig. 3) .
Modulation of unfolded protein response by the three identified compounds
To dissect the molecular mechanism of unfolded protein response (UPR) that may be modulated by the identified compounds, we examined the activity of UPR proteins after the cells were treated with thapsigargin in the presence or absence of the test compounds (Fig. 4) . Molecular events associated with UPR, including the induction of GRP78/Bip, a sensor of total UPR; the http://bmbreports.org BMB Reports inactivation of eIF2-α by phosphorylation of serine 51 residue; the activation of p38 MAP kinase by phosphorylation of threonine 180 and tyrosine 181 residues; the activation of caspase-3; and the splicing of XBP-1 messenger RNA were examined by immunoblotting and reverse transcription polymerase chain reaction (RT-PCR), as appropriate. It was observed that all the three inhibitor compounds upregulated GRP78 protein expression, and inhibited the inactivation of eIF2-α. Cyclosporine A and bromocriptine inhibited the activation of p38 MAPK (Fig. 4A) , while U74389G already induced activation of p38 MAP kinase through pre-incubation. In addition, the three compounds suppressed caspase-3 activation triggered by thapsigargin. However, none of these compounds affected XBP-1 mRNA splicing (Fig. 4B) .
We also assayed whether the ability of the three compounds to modulate UPR was also applicable to other ER stress inducers, because the three compounds did not inhibit ER stress-induced cell death initiated by tunicamycin or brefeldin A. It was observed that the three compounds did not inhibit tunicamycin-induced phosphorylation of eIF2-α (Fig. 4C ) in a different way from thapsigargin ( Fig. 4A) , thus indicating that these three cytoprotective hit compounds only inhibit ER stress signaling events triggered by thapsigargin.
DISCUSSION
The endoplasmic reticulum (ER) is an organelle involved in protein quality control, but its function can be inhibited by diverse stress-inducing conditions. Several cell-based assays have been utilized to identify compounds that inhibit ER stress-induced cell. Salubrinal, the first identified chemical inhibitor of ER stress-induced cell death (12), and benzodiazepinone derivatives (BZDs) (14, 16) suppresses cell death induced by thapsigargin, tunicamycin, and other inducers of ER stress (15) , indicating that they act on common cell death pathways activated during ER stress. Interestingly, salubrinal has been shown to arrest UPR signaling in the PERK pathway by modulating phosphorylation of eIF2-α, whereas BZD compounds operate downstream of IRE1, thus modulating phosphorylation of ASK1 (14, 16 ]i) by blocking calcium pumping into ER, resulting in the induction of ER stress by exerting effects on Ca 2+ -dependent chaperones, which reside in the ER. In addition to triggering ER stress-induced UPR, however, it is likely that thapsigargin also activates other Ca Our results indicate that cyclosporine A and bromocriptine are selective inhibitors of thapsigargin-triggered cell death, thus demonstrating their cytoprotective activity. The lipid peroxidation inhibitor, U74389G also showed protective activity but was less robust when compared to other inhibitors. Interestingly, we found that all of the identified compounds modified thapsigargin-induced (a) phosphorylation of the PERK substrate eIF2-α, and (b) phosphorylation of p38 MAPK, an event at downstream of IRE1 activation. Thus, signaling by at least two of the UPR pathways appears (e.g. IRE1 and PERK) to be affected by cyclosporin A, bromocryptine, and U74389G. Of note, U74389G was less potent in suppressing p38 MAPK, and also less effective in preserving cell survival, which was consistent with other evidence that state that activation of stress kinases contributes to apoptosis during ER stress (18) . Another intriguing feature of the identified compounds is their effects on GRP78 expression. At basal conditions, GRP78 protein levels were elevated by cyclosporin A, bromocryptine, and U74389G. Increased expression of GRP78, an Hsp70-family chaperone that resides predominantly in the lumen of the ER, would be expected to safeguard against ER stress by increasing the protein folding capacity. It is unclear therefore as why these compounds afforded cytoprotection only against thapsigargin, but not against Tunicamycin or Brefeldin A. Given that the promoter of the gene encoding GRP78 binds and responds to UPR-induced transcription factors, including ATF4 and ATF6 (19, 20) , we speculate that cyclosporin A, bromocryptine, and U74389G modulate targets that impact the homeostasis of gene networks that regulate cellular resistance to ER stress. Cyclosporine A is an immunosuppressant that is widely used to reduce immune rejection (21) . This natural product binds to cyclophilins with subsequent formation of complexes and inhibits calcineurin (22) , a Ca 2+ dependent protein phosphatase. One of calcineurin's important cell death substrate is BAD, a pro-apoptotic Bcl-2 family protein. Dephosphorylation of BAD releases it from the chaperone 14-3-3, thus allowing BAD to exhibit its pro-apoptotic function by dimerizing with anti-apoptotic Bcl-2 family proteins (22) . Cyclosporin A and other calcineurin inhibitors have been shown to protect neurons from Ca 2+ -dependent apoptosis induced by BAD dephosphorylation (22) . Additionally, cyclosporine A possess another documented cytoprotective activity via its ability to interact with mitochondrial cyclophilin D with subsequent suppression of Ca
2+
-induced opening of mitochondria permeability transition pores (MPTP). The opening of MPTP stimulates both apoptotic and non-apoptotic cell death mechanisms (23) . Bromocryptine is a dopamine receptor D2 agonist. Thisergoline derivative is used in the treatment of pituitary tumors, Parkinsonism, hyperprolactinemia, and type 2 diabetes. Previously, bromocriptine has been shown to induce apoptosis of pituitary adenoma cells in association with accumulation of p53 protein and reductions in Bcl-2 protein levels in contrary to the observed cytoprotective activity, (24, 25) . Conversely, bromocryptine has also been reported to protect cells from damage in-duced by reactive oxygen species, thus inhibiting cell death (26) . Recently, bromocryptine has been shown to activate NRF2-PI3K signaling, which is involved in the regulation of various antioxidant pathways (27, 28) . It is unclear whether the role of bromocryptine in cell death signaling is D2 receptor-dependent. However, activation of the NRF2 pathway was observed in both D2-expressing and -non-expressing cell culture models following bromocryptine treatment, implying that its cytoprotective function may be independent of physiological roles of this receptor (26) . Further studies are needed to determine whether bromocryptine's inhibition of cell death in the context of ER stress is associated with activation of the NRF2 pathway. The U74389G is an potent inhibitor of lipid peroxidation. Uncoupling of electrons between NADPH-dependent cytochrome P450 reductase (NPR) and cytochrome P450 2E1 (P450 2E1) is the main source of reactive oxygen species on the ER membrane. Although U74389G suppression of lipid peroxidation delays ER stress-induced cell death, the potency of U74389G in inhibiting thapsigargin-induced cell death was much weaker than cyclosporine A and bromocriptine. These findings suggest that the ROS-mediated cell stress response is one of the cell death mechanisms, which is activated by thapsigargin. However, given that, U74389G was relatively weak and inconsistent as a cell death protector; the role of lipid peroxidation in thapsigarin-induced cell death may be limited.
In conclusion, we identified cyclosporine A and bromocryptine as potent and selective inhibitors of ER stress-induced cell death triggered by calcium mobilizing agent, thapsigargin. Elucidation of the detailed mechanisms of action of these cytoprotective compounds in the context of cell death induced by Ca 2+ mobilization merits further evaluation. It will also be interesting to consider whether the cytoprotective actions of cyclosporin A and bromocryptine can be exploited as a drug re-purposing opportunity for mitigating against tissue injury in various pathological contexts, where either the roles of intracellular Ca 2+ dysregulation or ER stress are involved.
MATERIALS AND METHODS
Reagents
The 1280-Pharmacologically Active Compound library (LOPAC   TM   ) and follow-up compounds were purchased from Sigma Aldrich (St. Louis, MO). The Spectrum compound library was from MicroSource (Gardena, CA). The Celltiter Glo assay kit was from Promega.
Cell culture
Typically, SK-Mel, HCT116 and A549 cells were maintained in RPMI1640 medium. The CSM 14.1, HeLa, and MBA-MD-231 cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM), and RPMI-7951 cells were grown in Minimal Essential Medium (MEM). All the culture media were supplemented with 10% fetal bovine serum (FBS), 100 IU penicillin/streptomycin, and 1% L-glutamine.
High throughput compound screening
Typically, CSM 14.1 cells were recovered from cultures and seeded in 96 well plates at a density of 5 × 10 3 cells per well in 80 μl of media, and the plates were incubated overnight at 37 o C. Using an automated liquid handler system (Perkin Elmer model AJM8M01), 10 μl of test compound in 10% DMSO was added to wells to achieve final concentrations of 10 μM. Aliquots of 10 μL of salubrinal (final concentration 100 μM) were added to wells A-D in column 1. After 2 hours, 10 μl of thapsigargin containing medium (final concentration 15 μM) was added to each wellto induce cell death, except for the wells in column 12. To the wells in column 12 was added 10 μl of culture medium containing DMSO to yield the same DMSO concentration as in treated wells. After 20 hours, cell viability was assessed by a cellular ATP contents assay (PerkinElmer Life Science-ATPlite), using a Victor multi label counter (Perkin Elmer model 1420-050). Raw values were transferred to Excel software to evaluate relative cell survival rate. Wells in column 12 were used as experimental controls; wells in column 1, rows E through H were used as negative controls; and wells in column 1, rows A through D were used as positive controls. The quality of each assay plate was evaluated by calculating the Z' factor. To identify the effective compounds, a standard score for each tested sample was calculated using the equation, σ = (raw value of well -mean of total tested wells in a plate)/(standard deviation of total tested wells).
Cell viability
Following the induction of cell death with thapsigargin (TG), tunicamycin (TU), brefeldin A (BFA), tumor necrosis factor alpha (TNF-α), cycloheximide (CHX), and staurosporine (STS), relative cell viability was evaluated by measuring cellular ATP levels using bioluminescence microtiter plate reader assay (CellTiterGloPromega). To evaluate cell death induced by etoposide (ETO), cells were trypsinized and assessed by the trypan blue exclusion.
Immunoblotting
Cells were seeded at a density of 2 × 10 5 /well in 6-well plate. After overnight incubation, cells were treated with respective compounds for 2 hours followed by 15 μM TG for 20 hours. The cells were harvested and lysed in buffer containing 50 mM Tris-Cl, pH 7.4, 1% Nonidet P-40, 150 mM NaCl, 1 mM MgCl2,1 mM Na3VO4, 2.5 mM β-glycero-phosphate, and protease inhibitor (Roche Applied Science). After determination of the protein concentrations, extracts were boiled in Laemmli buffer, and 50 μg of each cell extract was resolved by SDS-PAGE and transferred to polyvinylidene fluoride membranes (Immobilon P -Millipore). Subsequently, the membraneswere incubated with specific antibodies (1：1,000). Antibody-antigen complexes were detected with horseradish peroxidase-conjugated immunoglobulin G (BioRad) and a chemiluminescent substrate kit (SuperSignal West Pico Chemiluminescent Substrate-Pierce). The membranes were incubated with antibody to α-tubulin as a loading control. http://bmbreports.org BMB Reports
